Systematic review of dasatinib in chronic myeloid leukemia
Massimo Breccia, Adriano Salaroli, Matteo Molica, Giuliana Alimena Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy Abstract: Dasatinib is a dual tyrosine kinase inhibitor active against ABL and Src family kinases, and is approved for the treatment of chronic m...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2013-03-01
|
| Series: | OncoTargets and Therapy |
| Online Access: | http://www.dovepress.com/systematic-review-of-dasatinib-in-chronic-myeloid-leukemia-a12602 |